CONMED Corp. buy Piper Sandler
Start price
01.02.24
/
50%
€77.50
Target price
01.02.25
€91.97
Performance (%)
-10.97%
End price
02.02.25
€69.00
Summary
This prediction ended on 02.02.25 with a price of €69.00. The price of CONMED Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.97%. Piper_Sandler has a follow-up prediction for CONMED Corp. where he still thinks CONMED Corp. is a Buy. A total of €0.74 was paid as dividends for this prediction. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | 8.725% | 8.725% | -28.319% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
Comments by Piper_Sandler for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $130.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten